Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

CT scans can find serious prostate cancer even when PSA levels are low.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Understanding where cancer cells come from helps create better prevention and treatment methods.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride may reduce prostate tumor cell invasion and spread.

Finasteride may improve prostate cancer treatment outcomes.

Certain Dibenzo derivatives may help treat prostate cancer.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

New compounds may help treat prostate cancer by reducing cell growth.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.